Code intelligence

E11.69 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code E11.69.

Normal code riskView ICD-10 detail

Signal breakdown

3 shown · 3 total in platform

Risk: Normal

Critical

High

Routine

100%

Low

New this month

—

alerts added in last 30 days

Effective soon

—

no upcoming deadlines

LCD L40199 (Notice Ends 08/09/2026): MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis — CGS Administrators

Policy LCD-L40199 · Clinical Laboratory

Routine

New MolDX LCD for MASLD/MASH biomarker tests effective Aug 2026.

View alert

LCD L40272 (Notice Ends 08/09/2026): MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis — WPS

Policy LCD-L40272 · Clinical Laboratory

Routine

New MolDX biomarker LCD for MASLD/MASH liver disease effective Aug 2026.

View alert

LCD L40187 (Notice Ends 08/09/2026): MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis — Palmetto GBA

Policy LCD-L40187 · Clinical Laboratory

Routine

New MolDX LCD for MASLD/MASH biomarker tests effective Aug 2026.

View alert

Audit documentation

Building an audit file that includes E11.69?

The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription